Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
HF Robertson, MJ Buckton & JF Apperley. (2023) Managing women of childbearing age with chronic myeloid leukemia: safety and treatment considerations. Expert Review of Hematology 16:5, pages 325-332.
Read now
Read now
Rita Assi, Hagop Kantarjian, Michael Keating, Naveen Pemmaraju, Srdan Verstovsek, Guillermo Garcia-Manero, Farhad Ravandi, Gautam Borthakur, Jenny Dahl, Elias Jabbour & Jorge E. Cortes. (2021) Management of chronic myeloid leukemia during pregnancy among patients treated with a tyrosine kinase inhibitor: a single-Center experience. Leukemia & Lymphoma 62:4, pages 909-917.
Read now
Read now
Masa Lasica, Abbey Willcox, Kate Burbury, David M. Ross, Susan Branford, Jason Butler, Robin Filshie, Henry Januszewicz, David Joske, Anthony Mills, David Simpson, Constantine Tam, Kerry Taylor, Anne-Marie Watson, Max Wolf & Andrew Grigg. (2019) The effect of tyrosine kinase inhibitor interruption and interferon use on pregnancy outcomes and long-term disease control in chronic myeloid leukemia. Leukemia & Lymphoma 60:7, pages 1796-1802.
Read now
Read now
Christel C. L. M. Boons, Vashti N. M. F. Tromp, Nienke J. M. Neppelenbroek, Lonneke Timmers, Natasja M. van Schoor, Eleonora L. Swart, N. Harry Hendrikse, Jeroen J. W. M. Janssen & Jacqueline G. Hugtenburg. (2019) Satisfaction with information on nilotinib treatment in chronic myeloid leukemia patients. Acta Oncologica 58:6, pages 891-896.
Read now
Read now
Philippe Rousselot. (2018) The story of tyrosine kinase inhibitors discontinuation in clinical practice. Leukemia & Lymphoma 59:12, pages 2782-2791.
Read now
Read now
Ekaterina Chelysheva, Anna Turkina, Evgenia Polushkina, Roman Shmakov, Alexey Zeifman, Sergey Aleshin, Igor Shokhin, Dorel Guranda, Oksana Oksenjuk, Sergey Mordanov, Khamida Kazakbaeva & Ghermes Chilov. (2018) Placental transfer of tyrosine kinase inhibitors used for chronic myeloid leukemia treatment. Leukemia & Lymphoma 59:3, pages 733-738.
Read now
Read now
Nicola Sgherza, Elisabetta Abruzzese, Gianni Perla, Maria Marta Minervini, Vincenzo Chiello, Natale Sciannamè & Nicola Cascavilla. (2017) Onset of chronic myeloid leukemia with complex karyotype in a pregnant patient: case report and revision of literature. Therapeutics and Clinical Risk Management 13, pages 751-755.
Read now
Read now
Ahmet Emre Eskazan. (2017) Do all patients with chronic myeloid leukemia need to receive interferon during pregnancy?. Leukemia & Lymphoma 58:8, pages 2019-2020.
Read now
Read now
Kamal Kant Sahu, Deba Prasad Dhibar, Subhash Varma & Pankaj Malhotra. (2017) CML with pregnancy: real challenges in developing nations. Leukemia & Lymphoma 58:6, pages 1518-1519.
Read now
Read now
Articles from other publishers (34)
Xiaomei I. Liu, Ruby Leong, Gilbert J. Burckart & André Dallmann. (2023) Physiologically Based Pharmacokinetic Modeling of Nilotinib for Drug‐Drug Interactions, Pediatric Patients, and Pregnancy and Lactation. The Journal of Clinical Pharmacology.
Crossref
Crossref
Kelly L. Schoenbeck & Kathryn E. Flynn. (2021) Health-Related Quality of Life of Patients with Chronic Myeloid Leukemia as Measured by Patient-Reported Outcomes: Current State and Future Directions. Current Hematologic Malignancy Reports 16:6, pages 491-499.
Crossref
Crossref
Xiaohui Chang, Xiaoxia Chen, Shu Wang, He Zhao, Lan Yao, Meiyun Fang, Xiaobo Wang, Yang Xiang & Lin Zhou. (2021) Imatinib reduces the fertility of male mice by penetrating the blood-testis barrier and inducing spermatogonia apoptosis. Reproductive Biology 21:3, pages 100527.
Crossref
Crossref
Anupama Rambhatla, Michael R. Strug, Jessica Garcia De Paredes, Marcos I. Cordoba Munoz & Mili Thakur. (2021) Fertility considerations in targeted biologic therapy with tyrosine kinase inhibitors: a review. Journal of Assisted Reproduction and Genetics 38:8, pages 1897-1908.
Crossref
Crossref
Massimo Breccia, Elisabetta Abruzzese, Mario Annunziata, Luigia Luciano & Simona Sica. (2021) Clinical and Psychological Factors to Consider in Achieving Treatment-Free Remission in Patients With Chronic Myeloid Leukemia. Frontiers in Oncology 11.
Crossref
Crossref
Mahmoud Vahidi, Ali Noroozi-Aghideh, Atefeh Entezari, Majid Zamani, Yoda Yaghoubi, Ali Hassanzadeh & Adel Naimi. (2021) Quercetin elicits proapoptotic effect through downregulation of antiapoptotic and upregulation of proapoptotic genes in human myeloid leukemia KG-1 cells. Annals of Cancer Research and Therapy 29:1, pages 96-101.
Crossref
Crossref
Manish Banker, Parul Arora, Jwal Banker & Sandeep Shah. (2021) Chemotherapy can interfere in implantation in in-vitro fertilization. Journal of Human Reproductive Sciences 14:1, pages 94.
Crossref
Crossref
Elisabetta Abruzzese & Jane F. Apperley. 2021. Chronic Myeloid Leukemia. Chronic Myeloid Leukemia
227
244
.
Giancarlo Fatobene, Ana Costa Cordeiro, Maria Cecília Borges Bittencourt & Rafael Fernandes Pessoa Mendes. 2021. Chemotherapy and Pharmacology for Leukemia in Pregnancy. Chemotherapy and Pharmacology for Leukemia in Pregnancy
23
48
.
Zsolt Szakács, Péter Jenő Hegyi, Nelli Farkas, Péter Hegyi, Márta Balaskó, Adrienn Erős, Szabina Szujó, Judit Pammer, Bernadett Mosdósi, Mária Simon, Arnold Nagy, Gabriella Für & Alizadeh Hussain. (2020) Pregnancy outcomes of women whom spouse fathered children after tyrosine kinase inhibitor therapy for chronic myeloid leukemia: A systematic review. PLOS ONE 15:12, pages e0243045.
Crossref
Crossref
Graeme Smith, Jane Apperley, Dragana Milojkovic, Nicholas C. P. Cross, Letizia Foroni, Jenny Byrne, Andy Goringe, Anupama Rao, Jamshid Khorashad, Hugues Lavallade, Adam J. Mead, Wendy Osborne, Chris Plummer, Gail Jones & Mhairi Copland. (2020) A British Society for Haematology Guideline on the diagnosis and management of chronic myeloid leukaemia. British Journal of Haematology 191:2, pages 171-193.
Crossref
Crossref
Deepam Pushpam & Sameer Bakhshi. (2020) Pharmacology of tyrosine kinase inhibitors in chronic myeloid leukemia; a clinician’s perspective. DARU Journal of Pharmaceutical Sciences 28:1, pages 371-385.
Crossref
Crossref
Mohammad Abu-Tineh, Nancy Kassem, Mohammad Abdul-Jaber Abdulla, Omar Mohammad Ismail, Khaldun Obeidat, Rola Ghasoub & Mohamed A. Yassin. (2020) Outcome of Pregnancy in the Era of PEGylated Interferon-α2a in Females with Chronic Myeloid Leukemia: An Experience from Qatar. Case Reports in Oncology 13:1, pages 291-294.
Crossref
Crossref
Elisabetta Abruzzese, Michael Mauro, Jane Apperley & Ekaterina Chelysheva. (2020) Tyrosine kinase inhibitors and pregnancy in chronic myeloid leukemia: opinion, evidence, and recommendations. Therapeutic Advances in Hematology 11, pages 204062072096612.
Crossref
Crossref
Zehra Narli Ozdemir & Sinem Civriz Bozdag. 2020. Cell Biology and Translational Medicine, Volume 9. Cell Biology and Translational Medicine, Volume 9
103
115
.
Michele BaccaraniElisabetta AbruzzeseVincenzo AccursoFrancesco AlbanoMario AnnunziataSara BarulliGermana BeltramiMicaela BergamaschiGianni BinottoMonica BocchiaGiovanni CaocciIsabella CapodannoFrancesco CavazziniMichele CedroneMarco CerranoMonica CrugnolaMariella D’AddaChiara ElenaCarmen FavaPaola FaziClaudio FozzaSara GalimbertiValentina GiaiAntonella GozziniGabriele GugliottaAlessandra IurloGaetano La BarbaLuciano LevatoAlessandro LucchesiLuigia LucianoFrancesca LunghiMonia LunghiMichele MalagolaRoberto MarascaBruno MartinoAngela MelpignanoMaria Cristina MiggianoEnrico MontefuscoCaterina MusolinoFausto PalmieriPatrizia PregnoDavide RapezziGiovanna Rege-CambrinSerena RupoliMarzia SalvucciRosaria SancettaSimona SicaRaffaele SpadanoFabio StagnoMario TiribelliSimona TomassettiElena Trabacchi, Massimiliano Bonifacio, Massimo BrecciaFausto CastagnettiFabrizio PaneDomenico RussoGiuseppe SaglioSimona SoveriniPaolo VigneriGianantonio Rosti. (2019) Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP. Blood Advances 3:24, pages 4280-4290.
Crossref
Crossref
Ali Hassanzadeh, Elham Hosseinzadeh, Saleheh Rezapour, Ghasem Vahedi, Navideh Haghnavaz & Faroogh Marofi. (2019) Quercetin Promotes Cell Cycle Arrest and Apoptosis and Attenuates the Proliferation of Human Chronic Myeloid Leukemia Cell Line-K562 Through Interaction with HSPs (70 and 90), MAT2A and FOXM1. Anti-Cancer Agents in Medicinal Chemistry 19:12, pages 1523-1534.
Crossref
Crossref
Xuelin Dou, Yazhen Qin, Xiaojun Huang & Qian Jiang. (2019) Planned Pregnancy in Female Patients with Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitor Therapy. The Oncologist 24:11, pages e1141-e1147.
Crossref
Crossref
Uma Athale, Nobuko Hijiya, Briana C. Patterson, John Bergsagel, Jeffrey R. Andolina, Henrique Bittencourt, Kirk R. Schultz, Michael J. Burke, Michele S. Redell, E. Anders Kolb & Donna L. Johnston. (2019) Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group. Pediatric Blood & Cancer 66:9.
Crossref
Crossref
David J Hermel, Victor Chiu, Melody H Hermel, Anil Tulpule & Mojtaba Akhtari. (2017) Cardiac birth defects in a twin infant born to a woman with chronic myeloid leukemia on dasatinib. Journal of Oncology Pharmacy Practice 25:3, pages 699-702.
Crossref
Crossref
Elisabetta Abruzzese, Paolo de Fabritiis, Malgorzata M. Trawinska, Pasquale Niscola, Jane F. Apperley & Michael J. Mauro. (2018) Back to the future: Treatment‐free remission and pregnancy in chronic myeloid leukemia. European Journal of Haematology 102:2, pages 197-199.
Crossref
Crossref
Deepam Pushpam & Sameer Bakhshi. (2019) Paediatric chronic myeloid leukaemia: Is it really a different disease?. Indian Journal of Medical Research 149:5, pages 600.
Crossref
Crossref
Ekaterina Yur'evna Chelysheva, A.G. Turkina, E.S. Polushkina, M.A. Vinogradova & R.G. Shmakov. (2019) Management of Chronic Myeloid Leukemia Patients During Pregnancy (Analysis of Literature and Practical Recommendations). Clinical oncohematology 12:2, pages 102-110.
Crossref
Crossref
Marie Balsat, Madeleine Etienne, Mohamed Elhamri, Sandrine Hayette, Gilles Salles & Xavier Thomas. (2018) Successful pregnancies in patients with BCR-ABL-positive leukemias treated with interferon-alpha therapy during the tyrosine kinase inhibitors era. European Journal of Haematology 101:6, pages 774-780.
Crossref
Crossref
Merav Barzilai, Irit Avivi & Odelia Amit. (2018) Hematological malignancies during pregnancy (Review). Molecular and Clinical Oncology.
Crossref
Crossref
Delphine Rea & Jean-Michel Cayuela. (2017) Treatment-free remission in patients with chronic myeloid leukemia. International Journal of Hematology 108:4, pages 355-364.
Crossref
Crossref
Pasquale Niscola, Fabio Efficace & Elisabetta Abruzzese. (2018) Sexual health in patients with hematological malignancies: a neglected issue. Supportive Care in Cancer 26:6, pages 1699-1701.
Crossref
Crossref
Elizabeth M. Staley, Sierra C. Simmons, Alexander Z. Feldman, Robin G. Lorenz, Marisa B. Marques, Lance A. WilliamsIIIIII, X. Long Zheng & Huy P. Pham. (2017) Management of chronic myeloid leukemia in the setting of pregnancy: when is leukocytapheresis appropriate? A case report and review of the literature. Transfusion 58:2, pages 456-460.
Crossref
Crossref
Christel C. L. M. Boons, Lonneke Timmers, Natasja M. van Schoor, Eleonora L. Swart, N. Harry Hendrikse, Jeroen J. W. M. Janssen & Jacqueline G. Hugtenburg. (2018) Patient satisfaction with information on oral anticancer agent use. Cancer Medicine 7:1, pages 219-228.
Crossref
Crossref
Mathieu Puyade, Emilie Cayssials, Fabrice Pierre & Olivier Pourrat. (2017) Pregnancy and myeloproliferative neoplasms : A retrospective monocentric cohort. Obstetric Medicine 10:4, pages 165-169.
Crossref
Crossref
Xiaohui Chang, Lin Zhou, Xiaoxia Chen, Baoli Xu, Yubin Cheng, Shujun Sun, Meiyun Fang & Yang Xiang. (2017) Impact of Imatinib on the Fertility of Male Patients with Chronic Myelogenous Leukaemia in the Chronic Phase. Targeted Oncology 12:6, pages 827-832.
Crossref
Crossref
Patrick Carlier, Nathalie Bernard, Laurence Lagarce, Anne Dautriche, Johana Béné, Nathalie Fouilhé Sam-Lai & Pirayeh Eftekhari. (2016) Pregnancy outcome among partners of male patients receiving imatinib, dasatinib or nilotinib in chronic myeloid leukemia: reports collected by the French network pharmacovigilance centers. Archives of Gynecology and Obstetrics 295:2, pages 269-271.
Crossref
Crossref
A. G. Turkina, E. Yu. Chelysheva, V. A. Shuvaev, G. A. Gusarova, A. V. Bykova, O. A. Shukhov, A. N. Petrova, M. V. Vakhrusheva, S. R. Goryacheva, L. Yu. Kolosova, P. S. Krasikova, M. S. Fominykh, I. S. Martynkevich, A. O. Abdullaev, A. B. Sudarikov & V. G. Savchenko. (2017) Results of following up patients with chronic myeloid leukemia and a deep molecular response without tyrosine kinase inhibitor therapy. Terapevticheskii arkhiv 89:12, pages 86.
Crossref
Crossref
Weiwei Sheng & Naitong Sun. (2016) Successful pregnancy and delivery in a patient with chronic myeloid leukemia: a case report and review of the literature. SpringerPlus 5:1.
Crossref
Crossref